Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Thummel

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|November 21, 2022
The plasma free fraction of 25-hydroxyvitamin D<sub>3</sub> is not strongly associated with 25-hydroxyvitamin D<sub>3</sub> clearance in kidney disease patients and controlsCora M Best, Kenneth E Thummel, Simon Hsu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 24, 2012
Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant miceDiana L Shuster, Theo K Bammler, Richard P Beyer, et al.
Plos One|November 2, 2017
Bi-cultural dynamics for risk and protective factors for cardiometabolic health in an Alaska Native (Yup'ik) populationJacques Philip, Tove K Ryman, Scarlett E Hopkins, et al.
The Journal of Clinical Investigation|July 15, 2006
Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammationChangcheng Zhou, Michelle M Tabb, Edward L Nelson, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2020
Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic StudySimon Hsu, Leila R Zelnick, Yvonne S Lin, et al.
Public Health Nutrition|July 29, 2016
Declines in traditional marine food intake and vitamin D levels from the 1960s to present in young Alaska Native womenDiane M O'Brien, Kenneth E Thummel, Lisa R Bulkow, et al.
Pharmacogenetics|October 30, 2003
Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitorsMary F Hebert, Amy L Dowling, Cynthia Gierwatowski, et al.
Molecular Pharmacology|October 7, 2005
Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalaciaYang Xu, Takanori Hashizume, Margaret C Shuhart, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2020
Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native PeopleMatthew G McDonald, Lindsay M Henderson, Sutapa Ray, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 30, 2015
The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 AllelesAmarjit S Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Steroid Biochemistry and Molecular Biology|November 21, 2022
The plasma free fraction of 25-hydroxyvitamin D<sub>3</sub> is not strongly associated with 25-hydroxyvitamin D<sub>3</sub> clearance in kidney disease patients and controlsCora M Best, Kenneth E Thummel, Simon Hsu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 24, 2012
Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant miceDiana L Shuster, Theo K Bammler, Richard P Beyer, et al.
Plos One|November 2, 2017
Bi-cultural dynamics for risk and protective factors for cardiometabolic health in an Alaska Native (Yup'ik) populationJacques Philip, Tove K Ryman, Scarlett E Hopkins, et al.
The Journal of Clinical Investigation|July 15, 2006
Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammationChangcheng Zhou, Michelle M Tabb, Edward L Nelson, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2020
Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic StudySimon Hsu, Leila R Zelnick, Yvonne S Lin, et al.
Public Health Nutrition|July 29, 2016
Declines in traditional marine food intake and vitamin D levels from the 1960s to present in young Alaska Native womenDiane M O'Brien, Kenneth E Thummel, Lisa R Bulkow, et al.
Pharmacogenetics|October 30, 2003
Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitorsMary F Hebert, Amy L Dowling, Cynthia Gierwatowski, et al.
Molecular Pharmacology|October 7, 2005
Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalaciaYang Xu, Takanori Hashizume, Margaret C Shuhart, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2020
Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native PeopleMatthew G McDonald, Lindsay M Henderson, Sutapa Ray, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 30, 2015
The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 AllelesAmarjit S Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, et al.
Pageof 16